1. Home
  2. MBBC vs CRVO Comparison

MBBC vs CRVO Comparison

Compare MBBC & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBBC

Marathon Bancorp Inc.

BUY

Current Price

$14.97

Market Cap

40.2M

Sector

Finance

ML Signal

BUY

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$3.86

Market Cap

37.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBBC
CRVO
Founded
1902
2001
Country
United States
United States
Employees
35
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.2M
37.4M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
MBBC
CRVO
Price
$14.97
$3.86
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$23.00
AVG Volume (30 Days)
12.0K
34.5K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,006,510.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$47.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.94
$3.51
52 Week High
$14.64
$13.13

Technical Indicators

Market Signals
Indicator
MBBC
CRVO
Relative Strength Index (RSI) 61.62 42.86
Support Level $12.93 $3.55
Resistance Level N/A $4.41
Average True Range (ATR) 0.41 0.27
MACD 0.07 0.02
Stochastic Oscillator 99.47 27.51

Price Performance

Historical Comparison
MBBC
CRVO

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: